BioArctic AB (FRA:B9A) Net Interest Margin (Bank Only) %


FRA:B9A BioArctic AB FRA:B9A
83 GF Score
Price €29.24
GF Value €43.89
Valuation Significantly Undervalued
! 5 Warning Signs
View Full Analysis

What is BioArctic AB Net Interest Margin (Bank Only) %?

Net Interest Margin (Bank Only) % only applies to banks.

FRA:B9A
83GF Score
BioArctic AB FRA:B9A
Net Interest Margin (Bank Only) % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is BioArctic AB (FRA:B9A) Overvalued in 2026?

Based on GuruFocus' analysis, BioArctic AB stock appears to be undervalued. The current stock price of €29.24 is trading 33.4% below its estimated GF Value™ of €43.89. GuruFocus considers BioArctic AB to be Significantly Undervalued.

Key valuation signals for FRA:B9A:

  • Net Interest Margin (Bank Only) %:
  • GF Value™: €43.89 vs. price of €29.24 (33.4% below fair value)
  • GF Score™: 83/100 with 5 warning signs

No single metric tells the full story. See the FRA:B9A stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

BioArctic AB Business Description

Address Warfvinges vag 35, Stockholm, SWE, SE-112 51
BioArctic AB is a research-based biopharmaceutical company focusing on disease-modifying treatments and diagnostics for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease, and ALS. Geographically, it derives a majority of its revenue from North America.
83GF Score

Get the complete analysis for FRA:B9A

Net Interest Margin (Bank Only) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€29.24
Price
€43.89
GF Value